BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2879064)

  • 1. Mechanisms of action of atrial natriuretic factor: clinical consequences.
    Gerzer R; Weil J; Strom T; Müller T
    Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms of action of atrial natriuretic factor.
    Gerzer R; Heim JM; Schütte B; Weil J
    Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
    Leitman DC; Murad F
    Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
    Drewett JG; Ziegler RJ; Trachte GJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is cyclic GMP a clinically useful marker for ANF action?
    Heim JM; Gottmann K; Weil J; Haufe MC; Gerzer R
    Z Kardiol; 1988; 77 Suppl 2():41-6. PubMed ID: 2841815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic factor in spontaneously hypertensive rats: concentration changes with the progression of hypertension and elevated formation of cyclic GMP.
    Takayanagi R; Imada T; Grammer RT; Misono KS; Naruse M; Inagami T
    J Hypertens Suppl; 1986 Oct; 4(3):S303-7. PubMed ID: 2878070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
    Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
    J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
    Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
    Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
    Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
    J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.
    Khurana ML; Pandey KN
    Arch Biochem Biophys; 1995 Jan; 316(1):392-8. PubMed ID: 7840642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
    Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
    Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
    Trachte GJ
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial natriuretic factor. Current data and future perspectives].
    Michel JB; Arnal JF
    Arch Mal Coeur Vaiss; 1990 Dec; 83(14):2111-21. PubMed ID: 2178342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Homologous and heterologous regulation of atrial natriuretic factor receptors in smooth muscle cells].
    Chabrier PE; Roubert P; Braquet P
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1249-51. PubMed ID: 2554838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
    Cahill PA; Hassid A
    J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in messenger RNA encoding atrial natriuretic hormone receptor A and C subtypes during hepatic regeneration.
    Patel TB; Nair BG; Padmini E; Rashed HM; Sun H
    Hepatology; 1995 Jun; 21(6):1682-9. PubMed ID: 7768513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
    Drewett JG; Ziegler RJ; Trachte GJ
    J Pharmacol Exp Ther; 1990 Nov; 255(2):497-503. PubMed ID: 1978729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.
    Waldman SA; Rapoport RM; Murad F
    J Biol Chem; 1984 Dec; 259(23):14332-4. PubMed ID: 6150043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
    Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
    J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.